✦ LIBER ✦

Profound suppression of hepatitis B virus replication with lamivudine

✍ Scribed by Ching Lung Lai; Man Fung Yuen

Publisher: John Wiley and Sons
Year: 2000
Tongue: English
Weight: 191 KB
Volume: 61
Category: Article
ISSN: 0146-6615
DOI: 10.1002/1096-9071(200007)61:3<367::aid-jmv15>3.0.co;2-a

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Antiviral activity of aucubin against he

Antiviral activity of aucubin against hepatitis B virus replication

✍ Il-Moo Chang 📂 Article 📅 1997 🏛 John Wiley and Sons 🌐 English ⚖ 91 KB 👁 2 views

Aucubin, an iridoid glycoside was found to suppress hepatitis B virus DNA replication in vitro in a 2.2.15 cell culture system. Aucubin itself did not exhibit antiviral activity, but it showed significant activity when preincubated with ␤-glucosidase. Aucubin possesses no cytotoxicity at a broad ran

Prevention of hepatitis B reactivation w

Prevention of hepatitis B reactivation with lamivudine in hepatitis B virus carriers with hematologic malignancies treated with chemotherapy—A prospective case series

✍ Themistoklis Vassiliadis; Vassilia Garipidou; Konstantinos Tziomalos; Vassilios 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 85 KB 👁 2 views

Lamivudine in the treatment of hepatitis

Lamivudine in the treatment of hepatitis B virus reactivation during cytotoxic chemotherapy

✍ Yeo, Winnie; Steinberg, Joyce L.; Tam, John S.; Chan, Paul K.S.; Leung, Nancy W. 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 English ⚖ 76 KB 👁 2 views

Hepatitis B virus (HBV) reactivation has been described in cancer patients who received cytotoxic/immunosuppressive therapy and may result in liver damage of varying degrees of severity. There is no known effective treatment. Lamivudine, a nucleoside analogue, has been found to suppress HBV replicat

Emergence of YMDD motif mutants of hepat

Emergence of YMDD motif mutants of hepatitis B virus during lamivudine treatment of immunocompetent type B hepatitis patients

✍ Seta, Toshikatsu; Yokosuka, Osamu; Imazeki, Fumio; Tagawa, Masami; Saisho, Hirom 📂 Article 📅 2000 🏛 John Wiley and Sons 🌐 English ⚖ 174 KB 👁 2 views

Lamivudine is an effective antiviral agent for the treatment of chronic type B hepatitis. Recent studies have shown the appearance of lamivudine resistant viruses with mutations at the tyrosine-methionine-aspartate-aspartate (YMDD) motif of the viral polymerase in hepatitis B virus (HBV) infected pa

Suppression of Hepatitis B Virus Surface

Suppression of Hepatitis B Virus Surface Antigen Secretion by Traditional Plant Medicines

✍ Wakana Goto; Ines Tomoco Kusumoto; Shigetoshi Kadota; Tsuneo Namba; Mashahiko Ku 📂 Article 📅 1996 🏛 John Wiley and Sons 🌐 English ⚖ 402 KB 👁 1 views

## Forty -three extracts of herbal medicines were tested for suppressing the secretion of hepatitis B virus (HBV) surface antigen (HBsAg) in v h o . Fourteen extracts were found to have appreciable effects in the experimental system using the PLC/PRF/5 cell line. Of them, the extracts of Rheum palm

Novel patterns of amino acid mutations i

Novel patterns of amino acid mutations in the hepatitis B virus polymerase in association with resistance to lamivudine therapy in Japanese patients with chronic hepatitis B

✍ Ogata, Norio; Fujii, Kyuichi; Takigawa, Shingo; Nomoto, Minoru; Ichida, Takafumi 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 English ⚖ 160 KB 👁 2 views

Lamivudine is effective in suppressing replication of hepatitis B virus (HBV). However, the emergence of HBV variants resistant to lamivudine is a concern. Lamivudine resistance has been attributed mainly to a substitution of isoleucine or valine for methionine at residue 550 (M550I or M550V) in the